The IDEA Collaboration

The IDEA Collaboration

moasc

1 month
4 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Afsaneh Barzi, MD of Keck School of Medicine presents the IDEA (International Duration Evaluation of Adjuvant Chemotherapy) collaboration which investigated the adjuvant oxaliplatin-based therapy for patients with high-risk stage II colorectal cancer.

Up Next Autoplay
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
3 Views
Cancer-News 6 days
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
62 Views
Cancer-News 6 days
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
26 Views
Cancer-News 2 weeks
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 1 month
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
1 Views
Cleveland Clinic 1 month
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
10 Views
Cleveland Clinic 1 month
IDEA: Factors to consider
IDEA: Factors to consider
Category: Colorectal Cancer
2 Views
moasc 1 month
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
1 Views
moasc 1 month
IDEA: 3 vs. 6 months
IDEA: 3 vs. 6 months
Category: Colorectal Cancer
1 Views
moasc 1 month